Septerna, Inc.

This early-stage study tests the safety and how the body handles the experimental drug SEP-479 in 150 healthy adults aged 21 to 60. Participants receive single or multiple doses of the drug or a placebo. The goal is to check for side effects and measure drug levels in the blood, …